{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:14:52Z","timestamp":1776435292962,"version":"3.51.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["202003N4254"],"award-info":[{"award-number":["202003N4254"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01755-5","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:47:55Z","timestamp":1739177275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of long-stranded non-coding RNA-BANCR on the progression of thyroid papillary carcinoma and its mechanism"],"prefix":"10.1007","volume":"16","author":[{"given":"Jiayi","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongbo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"1","key":"1755_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"CD Seib","year":"2019","unstructured":"Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am. 2019;48(1):23\u201335.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"1755_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.surg.2019.03.040","volume":"167","author":"B Saravana-Bawan","year":"2020","unstructured":"Saravana-Bawan B, Bajwa A, Paterson J, McMullen T. Active surveillance of low-risk papillary thyroid cancer: a meta-analysis. Surgery. 2020;167(1):46\u201355.","journal-title":"Surgery"},{"issue":"3","key":"1755_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.21053\/ceo.2022.00206","volume":"15","author":"JW Yi","year":"2022","unstructured":"Yi JW, Ha SY, Jee HG, Kim K, Kim SJ, Chai YJ, Choi JY, Lee KE. Induction of the BRAFV600E mutation in thyroid cells leads to frequent hypermethylation. Clin Exp Otorhinolaryngol. 2022;15(3):273\u201382.","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"2","key":"1755_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ecl.2008.02.003","volume":"37","author":"RL Neff","year":"2008","unstructured":"Neff RL, Farrar WB, Kloos RT, Burman KD. Anaplastic thyroid cancer. Endocrinol Metab Clin North Am. 2008;37(2):525\u201338.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"41","key":"1755_CR5","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"WX Peng","year":"2017","unstructured":"Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661\u20137.","journal-title":"Oncogene"},{"issue":"2","key":"1755_CR6","first-page":"2009","volume":"16","author":"H Zheng","year":"2018","unstructured":"Zheng H, Xu J, Hao S, Liu X, Ning J, Song X, Jiang L, Liu Z. Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor. Oncol Lett. 2018;16(2):2009\u201315.","journal-title":"Oncol Lett"},{"issue":"7","key":"1755_CR7","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.7150\/jca.20150","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang J, Du Y, Zhang X, Li M, Li X. Downregulation of BANCR promotes aggressiveness in papillary thyroid cancer via the MAPK and PI3K pathways. J Cancer. 2018;9(7):1318\u201328.","journal-title":"J Cancer"},{"issue":"1","key":"1755_CR8","first-page":"1","volume":"1","author":"A Ahmad","year":"2017","unstructured":"Ahmad A. Non-coding RNAs: a tale of junk turning into treasure. Noncoding RNA Res. 2017;1(1):1\u20132.","journal-title":"Noncoding RNA Res"},{"issue":"4","key":"1755_CR9","first-page":"5865","volume":"15","author":"Y Wang","year":"2018","unstructured":"Wang Y, Gu J, Lin X, Yan W, Yang W, Wu G. lncRNA BANCR promotes EMT in PTC via the Raf\/MEK\/ERK signaling pathway. Oncol Lett. 2018;15(4):5865\u201370.","journal-title":"Oncol Lett"},{"issue":"2","key":"1755_CR10","first-page":"859","volume":"40","author":"Y Wang","year":"2018","unstructured":"Wang Y, Lin X, Fu X, Yan W, Lin F, Kuang P, Luo Y, Lin E, Hong X, Wu G. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF\/MEK\/ERK signaling pathway. Oncol Rep. 2018;40(2):859\u201366.","journal-title":"Oncol Rep"},{"issue":"1","key":"1755_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.18632\/oncotarget.10825","volume":"8","author":"T Liao","year":"2017","unstructured":"Liao T, Qu N, Shi RL, Guo K, Ma B, Cao YM, Xiang J, Lu ZW, Zhu YX, Li DS, Ji QH. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer. Oncotarget. 2017;8(1):238\u201347.","journal-title":"Oncotarget"},{"issue":"11","key":"1755_CR12","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cncr.21073","volume":"103","author":"RM Quiros","year":"2005","unstructured":"Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer. 2005;103(11):2261\u20138.","journal-title":"Cancer"},{"issue":"2","key":"1755_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.4143\/crt.2015.118","volume":"48","author":"H Zheng","year":"2016","unstructured":"Zheng H, Wang M, Jiang L, Chu H, Hu J, Ning J, Li B, Wang D, Xu J. BRAF-activated long noncoding RNA modulates papillary thyroid carcinoma cell proliferation through regulating thyroid stimulating hormone receptor. Cancer Res Treat. 2016;48(2):698\u2013707.","journal-title":"Cancer Res Treat"},{"issue":"2","key":"1755_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1530\/eje.0.1340177","volume":"134","author":"D Salvatore","year":"1996","unstructured":"Salvatore D, Celetti A, Fabien N, Paulin C, Martelli ML, Battaglia C, Califano D, Monaco C, Viglietto G, Santoro M, Fusco A. Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fifty-six thyroid tumours. Eur J Endocrinol. 1996;134(2):177\u201383.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1755_CR15","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1158\/0008-5472.CAN-21-0145","volume":"81","author":"JJ Manfredi","year":"2021","unstructured":"Manfredi JJ. Mdm2 and MdmX: partners in p53 destruction. Cancer Res. 2021;81(7):1633\u20134.","journal-title":"Cancer Res"},{"key":"1755_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.39.1.295","volume":"39","author":"DG Johnson","year":"1999","unstructured":"Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999;39:295\u2013312.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1\u20133","key":"1755_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mrrev.2010.01.009","volume":"704","author":"O Cazzalini","year":"2010","unstructured":"Cazzalini O, Scovassi AI, Savio M, Stivala LA, Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res. 2010;704(1\u20133):12\u201320.","journal-title":"Mutat Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01755-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01755-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01755-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:47:57Z","timestamp":1739177277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01755-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1755"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01755-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has received approval from the Ethics Committee of Ningbo First Hospital (Approval No. 2021-R050). Informed consent was obtained from all the participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agreed to the publication of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}